but you also have electric bills going up, and up because of lack of base load supply, and the additional infrastructure wiring costs to connect the solar and wind farms, passed on to consumers in their bill. Which will encourage more to add the roof top solar, plus battery, increasing home battery demand.Perhaps a near surface high grade deposit , DMS, with a large chunk of the capital already place is what makes the economics of WR1 - Adina - Renard the king.
Good Economics requires near surface, good grades, low strip ratio, DMS, all the cost savers on the tonnage.
Add then access to Quebec hydro. While Renard has its own gas power station, enabling immediate access to power, cheaper Hydro power was still a future possibility.
Having the capital largely in place, means that the banking decision, the finance is only looking at a smaller amount to repay. If there is a share of debt / equity on approx 200m capex remaining, a bank finance of say 100m ? Is far more reachable than the 1b than many others face. Final financial decision to mine looks at all these things.
It all comes down to, is anyone, shareholders or bankers going to lend you the money and view a payback period acceptable. And then when the capex is repaid, its gravy time.
- Forums
- ASX - By Stock
- WR1
- WR1 General Discussion
WR1 General Discussion, page-31473
Featured News
Add WR1 (ASX) to my watchlist
|
|||||
Last
67.5¢ |
Change
-0.005(0.74%) |
Mkt cap ! $144.9M |
Open | High | Low | Value | Volume |
68.0¢ | 68.5¢ | 67.0¢ | $88.08K | 130.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3800 | 67.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
67.5¢ | 4849 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3800 | 0.670 |
3 | 8834 | 0.665 |
8 | 117645 | 0.660 |
8 | 72243 | 0.655 |
10 | 50531 | 0.650 |
Price($) | Vol. | No. |
---|---|---|
0.675 | 4849 | 4 |
0.680 | 8399 | 3 |
0.685 | 28072 | 5 |
0.690 | 16824 | 3 |
0.695 | 4050 | 1 |
Last trade - 11.53am 16/07/2024 (20 minute delay) ? |
Featured News
WR1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online